These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Intranasal steroids versus placebo or no intervention for chronic rhinosinusitis. Chong LY, Head K, Hopkins C, Philpott C, Schilder AG, Burton MJ. Cochrane Database Syst Rev; 2016 Apr 26; 4(4):CD011996. PubMed ID: 27115217 [Abstract] [Full Text] [Related]
6. The Effect of Corticosteroids on Sinus Microbiota in Chronic Rhinosinusitis Patients with Nasal Polyposis. Alammar Y, Rousseau S, Desrosiers M, Tewfik MA. Am J Rhinol Allergy; 2023 Nov 26; 37(6):638-645. PubMed ID: 37475202 [Abstract] [Full Text] [Related]
9. Topical Steroids in Rhinosinusitis and Intraoperative Bleeding: More Harm Than Good? Tirelli G, Lucangelo U, Sartori G, Da Mosto MC, Boscolo-Rizzo P, Bussani R, Boscolo Nata F, Gatto A, Bonini P, Tofanelli M. Ear Nose Throat J; 2020 Jul 26; 99(6):388-394. PubMed ID: 31119988 [Abstract] [Full Text] [Related]
10. Pharmacologic management of chronic rhinosinusitis, alone or with nasal polyposis. Gillespie MB, Osguthorpe JD. Curr Allergy Asthma Rep; 2004 Nov 26; 4(6):478-85. PubMed ID: 15462715 [Abstract] [Full Text] [Related]
11. Endoscopic outcomes in patients with AERD treated with topical antibiotics and intranasal corticosteroids. Martinez-Paredes JF, Choby G, Marino M, Lal D, Olomu O, Alfakir R, Stokken JK, O'Brien E, Donaldson AM. Front Cell Infect Microbiol; 2022 Nov 26; 12():812215. PubMed ID: 35959364 [Abstract] [Full Text] [Related]
12. Dupilumab in chronic rhinosinusitis with nasal polyposis: current status, challenges, and future perspectives. Li T, Yin J, Yang Y, Wang G, Zhang Y, Song X. Expert Rev Clin Immunol; 2023 Nov 26; 19(8):939-948. PubMed ID: 37378551 [Abstract] [Full Text] [Related]
13. Predictors of Disease Control After Endoscopic Sinus Surgery Plus Long-Term Local Corticosteroids in CRSwNP. De Corso E, Settimi S, Tricarico L, Mele DA, Mastrapasqua RF, Di Cesare T, Salvati A, Trozzi L, De Vita C, Romanello M, Paludetti G, Galli J. Am J Rhinol Allergy; 2021 Jan 26; 35(1):77-85. PubMed ID: 32564684 [Abstract] [Full Text] [Related]
14. Lack of additive benefit of oral steroids on short-term postoperative outcomes in nasal polyposis. Arancibia C, Langdon C, Mullol J, Alobid I. Laryngoscope; 2020 Dec 26; 130(12):2742-2747. PubMed ID: 31755989 [Abstract] [Full Text] [Related]
15. The use of postoperative topical corticosteroids in chronic rhinosinusitis with nasal polyps: a systematic review and meta-analysis. Fandiño M, Macdonald KI, Lee J, Witterick IJ. Am J Rhinol Allergy; 2013 Dec 26; 27(5):e146-57. PubMed ID: 24119596 [Abstract] [Full Text] [Related]
16. Oral steroid therapy in chronic rhinosinusitis with and without nasal polyposis. Howard BE, Lal D. Curr Allergy Asthma Rep; 2013 Apr 26; 13(2):236-43. PubMed ID: 23225105 [Abstract] [Full Text] [Related]
17. Effect of postoperative systemic prednisolone on short-term and long-term outcomes in chronic rhinosinusitis with nasal polyps: A multi-centered randomized clinical trial. Mueller SK, Wendler O, Mayr S, Traxdorf M, Hosemann W, Olze H, Steinhart H, Wiegand S, Teymoortash A, Kuehnel T, Hackenberg S, Hummel T, Ambrosch P, Fazel A, Schick B, Baenkler HW, Koch M, Buerner H, Mantsopoulos K, Grundtner P, Nocera A, Agaimy A, Bleier B, Iro H. Front Immunol; 2023 Apr 26; 14():1075066. PubMed ID: 36969262 [Abstract] [Full Text] [Related]
18. State of the Art Medical Management of Nasal Polyps. Staricha KL, Ali HM, Stokken JK. Am J Rhinol Allergy; 2023 Mar 26; 37(2):153-161. PubMed ID: 36848283 [Abstract] [Full Text] [Related]
19. Systemic corticosteroids for allergic fungal rhinosinusitis and chronic rhinosinusitis with nasal polyposis: a comparative study. Landsberg R, Segev Y, DeRowe A, Landau T, Khafif A, Fliss DM. Otolaryngol Head Neck Surg; 2007 Feb 26; 136(2):252-7. PubMed ID: 17275549 [Abstract] [Full Text] [Related]
20. Efficacy and safety of dupilumab in patients with severe chronic rhinosinusitis with nasal polyps (LIBERTY NP SINUS-24 and LIBERTY NP SINUS-52): results from two multicentre, randomised, double-blind, placebo-controlled, parallel-group phase 3 trials. Bachert C, Han JK, Desrosiers M, Hellings PW, Amin N, Lee SE, Mullol J, Greos LS, Bosso JV, Laidlaw TM, Cervin AU, Maspero JF, Hopkins C, Olze H, Canonica GW, Paggiaro P, Cho SH, Fokkens WJ, Fujieda S, Zhang M, Lu X, Fan C, Draikiwicz S, Kamat SA, Khan A, Pirozzi G, Patel N, Graham NMH, Ruddy M, Staudinger H, Weinreich D, Stahl N, Yancopoulos GD, Mannent LP. Lancet; 2019 Nov 02; 394(10209):1638-1650. PubMed ID: 31543428 [Abstract] [Full Text] [Related] Page: [Next] [New Search]